LONGITUDINAL TRENDS IN RENAL FUNCTION IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUES

被引:0
|
作者
Kim, Donghee
Kim, W. Ray
Udompap, Prowpanga
Ahmed, Aijaz
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1498
引用
收藏
页码:S1133 / S1133
页数:1
相关论文
共 50 条
  • [31] When to stop nucleos(t)ide analogues in chronic hepatitis
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 15 - 15
  • [32] Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
    Zoulim, Fabien
    Locarnini, Stephen
    GASTROENTEROLOGY, 2009, 137 (05) : 1593 - 1608
  • [33] Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
    Hsu, Yao-Chun
    Wu, Chun-Ying
    Lane, Hsien-Yuan
    Chang, Chi-Yang
    Tai, Chi-Ming
    Tseng, Cheng-Hao
    Lo, Gin-Ho
    Perng, Daw-Shyong
    Lin, Jaw-Town
    Mo, Lein-Ray
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1920 - 1927
  • [34] Antiviral therapy with nucleos (t)ide analogues for severe chronic hepatitis B Reply
    Chen, Jun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (04) : 439 - 439
  • [35] Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy
    Tseng, Chao-Ming
    Chen, Tai-Been
    Hsu, Yao-Chun
    Chang, Chi-Yang
    Lin, Jaw-Town
    Mo, Lein-Ray
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (04) : 421 - 429
  • [36] Durability of Nucleos(t)ide Analogues Treatment in Patients with Chronic Hepatitis B: The Role of APASL Guideline
    Huang, Yi-Hsiang
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Lin, Han-Chieh
    HEPATOLOGY, 2014, 60 : 1122A - 1122A
  • [37] Risk Factor Analysis of HCC For Chronic Hepatitis B Patients With Nucleos(t)ide Analogues Therapy
    Yang, Liu-Qing
    Li, Xiang-yong
    Wu, Yuankai
    Chong, Yutian
    HEPATOLOGY, 2012, 56 : 360A - 360A
  • [38] HCC onset and features among chronic hepatitis B patients treated with nucleos(t)ide analogues
    Schranz, M.
    De Giorgio, M.
    Conte, G.
    Pasulo, L.
    Magini, G.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E66 - E66
  • [39] Short-term response and safety of nucleos(t)ide analogues in patients with chronic hepatitis B
    Mateos, M.
    Elberdin, L.
    Ramudo, L.
    Cid, P.
    Margusino, L.
    Martin, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 978 - 979
  • [40] Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits
    Korkmaz, Pinar
    Demirtuerk, Nese
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2024, 6 (02): : 70 - 77